Rightslink® by Copyright Clearance Center

A novel colchicine-binding site inhibitor suppresses triple-negative breast cancer growth and metastasis and synergizes with anti-PD-L1 immunotherapy in an immunogenic cancer model

Author:

Kelli L. Adeleye,Damilola Oluwalana,Raisa Krutilina,Yang Xie,Satyanarayana Pochampally,Lily Waltz,Gustavo A. Miranda-Carboni,Duane D. Miller,Tiffany N. Seagroves,Wei Li

Publication:

Biomedicine & Pharmacotherapy

Publisher:

Elsevier

Date:

May 2026

Please select your organization and/or account

Organization

Account

Please select your account from the above dropdown list. These accounts represent the offices, campuses, and other sites where your organization operates. Your account selection should match where you typically have an office or workspace. Even when you are traveling or temporarily working elsewhere, you should select the account that represents where you customarily work.

Cancel OK

Content Excluded

This content has been excluded from the RightsLink's service. Please contact Elsevier directly with your request.

This order request cannot be granted automatically by RightsLink.

To process your order please contact:
Elsevier Paris
permissionsfrance@elsevier.com